Exact Mass: 321.1762

Exact Mass Matches: 321.1762

Found 93 metabolites which its exact mass value is equals to given mass value 321.1762, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Arginylphenylalanine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C15H23N5O3 (321.1801)


Arginylphenylalanine is a dipeptide composed of arginine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Phenylalanylarginine

(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C15H23N5O3 (321.1801)


Phenylalanylarginine is a dipeptide composed of phenylalanine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

3-[[3-Methoxy-5-(1H-pyrrol-2-yl)pyrrol-2-ylidene]methyl]-1,4-dimethyl-4,5,6,7-tetrahydro-2H-isoindole

3-[[3-Methoxy-5-(1H-pyrrol-2-yl)pyrrol-2-ylidene]methyl]-1,4-dimethyl-4,5,6,7-tetrahydro-2H-isoindole

C20H23N3O (321.1841)


   

Gabexate

ethyl 4-[(6-carbamimidamidohexanoyl)oxy]benzoate

C16H23N3O4 (321.1688)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Impromidine

N-[3-(1H-imidazol-5-yl)propyl]-N-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine

C14H23N7S (321.1736)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D017442 - Histamine Agonists

   

1-Pentyl-3-(4-methoxybenzoyl)indole

(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

C21H23NO2 (321.1729)


   

(2S)-2-(2-Benzamidoethylamino)-5-(diaminomethylideneamino)pentanoic acid

5-Carbamimidamido-2-[(2-{[hydroxy(phenyl)methylidene]amino}ethyl)amino]pentanoate

C15H23N5O3 (321.1801)


   
   

RCS-4

(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

C21H23NO2 (321.1729)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists

   

gabexate

gabexate

C16H23N3O4 (321.1688)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   
   

6-O-beta-D-glucopyranosyl-1,2,3-trideoxy-1-C-ethyl-beta-galactonojirimycin

6-O-beta-D-glucopyranosyl-1,2,3-trideoxy-1-C-ethyl-beta-galactonojirimycin

C14H27NO7 (321.1787)


   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methylbenzamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methylbenzamide

C21H23NO2 (321.1729)


   

Pleiocarpamine

Pleiocarpamine

C21H23NO2 (321.1729)


   

Isolobelanine

Isolobelanine

C21H23NO2 (321.1729)


   

Cycloprodigiosin

Cycloprodigiosin

C20H23N3O (321.1841)


   

RCS-4 3-Methoxy isomer

RCS-4 3-Methoxy isomer

C21H23NO2 (321.1729)


   

H-GLY-VAL-PHE-OH

H-GLY-VAL-PHE-OH

C16H23N3O4 (321.1688)


   
   
   
   
   
   
   
   
   

Carboxyterbinafine

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

C21H23NO2 (321.1729)


   

Arg-phe

2-(2-amino-3-phenylpropanamido)-5-carbamimidamidopentanoic acid

C15H23N5O3 (321.1801)


A dipeptide formed from L-arginine and L-phenylalanine residues. It exhibits vasorelaxant activity.

   

Phe-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-phenylpropanoic acid

C15H23N5O3 (321.1801)


A dipeptide composed of L-phenylalanine and L-arginine joined by a peptide linkage.

   

RCS-4 2-methoxy isomer

RCS-4 2-methoxy isomer

C21H23NO2 (321.1729)


   

1-boc-4-(carboxy-pyridin-4-yl-methyl)-piperazine

1-boc-4-(carboxy-pyridin-4-yl-methyl)-piperazine

C16H23N3O4 (321.1688)


   

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-3-YL-ACETICACID

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-3-YL-ACETICACID

C16H23N3O4 (321.1688)


   

2-(2-(4-AMINOPIPERIDIN-1-YL)-2-PHENYLETHOXY)BENZONITRILE

2-(2-(4-AMINOPIPERIDIN-1-YL)-2-PHENYLETHOXY)BENZONITRILE

C20H23N3O (321.1841)


   

(6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-METHYLPYRIDIN-3-YL)BORONIC ACID

(6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-METHYLPYRIDIN-3-YL)BORONIC ACID

C15H24BN3O4 (321.186)


   

3-amino-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoic acid

3-amino-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoic acid

C16H23N3O4 (321.1688)


   

T6NJ &RBR&R

T6NJ &RBR&R

C23H20BN (321.1689)


   

2-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

2-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

C16H23N3O4 (321.1688)


   

6-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

6-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

C16H23N3O4 (321.1688)


   

1-(3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

1-(3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

C17H25BClNO2 (321.1667)


   

2-(4-BOC-PIPERAZINYL)-2-(3-PYRIDINYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(3-PYRIDINYL)ACETIC ACID

C16H23N3O4 (321.1688)


   

4-(5-CARBOXY-PYRIDIN-2-YL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(5-CARBOXY-PYRIDIN-2-YL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H23N3O4 (321.1688)


   

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-2-YL-ACETICACID

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-2-YL-ACETICACID

C16H23N3O4 (321.1688)


   

2-(tert-Butoxycarbonylamino)pyrimidine-5-boronic acid pinacol ester

2-(tert-Butoxycarbonylamino)pyrimidine-5-boronic acid pinacol ester

C15H24BN3O4 (321.186)


   

Tazofelone

5-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidin-4-one

C18H27NO2S (321.1762)


C308 - Immunotherapeutic Agent > C574 - Immunosuppressant

   

TERT-BUTYL 4-(3-NITROBENZYL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(3-NITROBENZYL)PIPERAZINE-1-CARBOXYLATE

C16H23N3O4 (321.1688)


   

1-benzyl-4-(1,2,3,4-tetrahydro-2-oxo-3-quinazolinyl)piperidine

1-benzyl-4-(1,2,3,4-tetrahydro-2-oxo-3-quinazolinyl)piperidine

C20H23N3O (321.1841)


   

6-Amino-1-isopropyl-4-(4-isopropylphenyl)-2(1H)-quinazolinone

6-Amino-1-isopropyl-4-(4-isopropylphenyl)-2(1H)-quinazolinone

C20H23N3O (321.1841)


   

tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate

tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate

C16H23N3O4 (321.1688)


   

TERT-BUTYL4-(2-NITROPHENYLAMINO)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL4-(2-NITROPHENYLAMINO)PIPERIDINE-1-CARBOXYLATE

C16H23N3O4 (321.1688)


   

Pentazocine hydrochloride

(+)-PENTAZOCINE MIXED AGONIST/ANTAGON

C19H28ClNO (321.1859)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]morpholine

4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]morpholine

C16H23N3O4 (321.1688)


   

4-(3-carboxy-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester

4-(3-carboxy-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester

C16H23N3O4 (321.1688)


   

tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate

tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate

C16H23N3O4 (321.1688)


   

tert-butyl 4-(2-methyl-4-nitrophenyl)piperazine-1-carboxylate

tert-butyl 4-(2-methyl-4-nitrophenyl)piperazine-1-carboxylate

C16H23N3O4 (321.1688)


   

4,5,6,7-Tetrahydro-3-((3-methoxy-5-(1H-pyrrol-2-yl)2H-pyrrol-2-ylidene)methyl)-1,4-dimethyl-2H-isoindole

4,5,6,7-Tetrahydro-3-((3-methoxy-5-(1H-pyrrol-2-yl)2H-pyrrol-2-ylidene)methyl)-1,4-dimethyl-2H-isoindole

C20H23N3O (321.1841)


   

L-Phenylalanyl-L-valylglycine

L-Phenylalanyl-L-valylglycine

C16H23N3O4 (321.1688)


   

3,6-Diacetyl-9-isoamylcarbazole

3,6-Diacetyl-9-isoamylcarbazole

C21H23NO2 (321.1729)


   

3,6-Diacetyl-9-n-amylcarbazole

3,6-Diacetyl-9-n-amylcarbazole

C21H23NO2 (321.1729)


   

2-Amino-3-(2,2-dimethylpropyl)-5,5-diphenylimidazol-4-one

2-Amino-3-(2,2-dimethylpropyl)-5,5-diphenylimidazol-4-one

C20H23N3O (321.1841)


   

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(7-methoxynaphthalen-1-yl)methanone

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(7-methoxynaphthalen-1-yl)methanone

C21H23NO2 (321.1729)


   

(2S)-2-(2-Benzamidoethylamino)-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-(2-Benzamidoethylamino)-5-(diaminomethylideneamino)pentanoic acid

C15H23N5O3 (321.1801)


   

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

C21H23NO2 (321.1729)


   

2-[[(1-Propan-2-yl-2-benzimidazolyl)amino]methyl]-6-prop-2-enylphenol

2-[[(1-Propan-2-yl-2-benzimidazolyl)amino]methyl]-6-prop-2-enylphenol

C20H23N3O (321.1841)


   

3-[4-[(2-Hydroxy-5-phenylphenyl)methyl]-1-piperazinyl]propanenitrile

3-[4-[(2-Hydroxy-5-phenylphenyl)methyl]-1-piperazinyl]propanenitrile

C20H23N3O (321.1841)


   

4-[4-[(1S,5R)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide

4-[4-[(1S,5R)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide

C20H23N3O (321.1841)


   
   
   
   
   

(3S,4S)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

(3S,4S)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

(3R,4R)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

(3R,4R)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

4-[2-(2-Methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

4-[2-(2-Methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

Arginylphenylalanine

Arginylphenylalanine

C15H23N5O3 (321.1801)


   
   
   

CM10

CM10

C20H23N3O (321.1841)


CM10 is a potent and selective aldehyde dehydrogenase 1A (ALDH1A) family inhibitor, with IC50s of 1700, 740, and 640 nM for ALDH1A1, ALDH1A2, and ALDH1A3, respectively. CM10 does not inhibit any of the other ALDH family members. CM10 can regulate metabolism and has anti-cancer activity[1].

   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-2-enamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-2-enamide

C16H23N3O4 (321.1688)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-3-enamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-3-enamide

C16H23N3O4 (321.1688)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-3-enamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-3-enamide

C16H23N3O4 (321.1688)


   

(5r)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

(5r)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

3,3'-bis(indolylmethyl)dimethyl ammonium hydroxide

3,3'-bis(indolylmethyl)dimethyl ammoniumhydroxide

C20H23N3O (321.1841)


{"Ingredient_id": "HBIN007160","Ingredient_name": "3,3'-bis(indolylmethyl)dimethyl ammonium hydroxide","Alias": "3,3'-bis(indolylmethyl)dimethyl ammoniumhydroxide","Ingredient_formula": "C20H23N3O","Ingredient_Smile": "C[N+](C)(CC1=CNC2=CC=CC=C21)CC3=CNC4=CC=CC=C43.[OH-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30672;2472","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-[(2r,6s)-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

2-[(2r,6s)-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

C21H23NO2 (321.1729)


   

5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

2-[6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

2-[6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

C21H23NO2 (321.1729)


   

(z,5e)-5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1h-2,2'-bipyrrolylidene

(z,5e)-5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1h-2,2'-bipyrrolylidene

C20H23N3O (321.1841)


   
   

methyl (11s,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

methyl (11s,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

C21H23NO2 (321.1729)


   

methyl (11s,13e,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

methyl (11s,13e,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

C21H23NO2 (321.1729)


   

(5z)-5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1'h-2,2'-bipyrrole

(5z)-5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1'h-2,2'-bipyrrole

C20H23N3O (321.1841)


   

(5s)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

(5s)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1'h-2,2'-bipyrrole

5-[(3,7-dimethyl-4,5,6,7-tetrahydro-2h-isoindol-1-yl)methylidene]-4-methoxy-1'h-2,2'-bipyrrole

C20H23N3O (321.1841)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n-methylbenzamide

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n-methylbenzamide

C21H23NO2 (321.1729)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-2-enamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-2-enamide

C16H23N3O4 (321.1688)